Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the beneficial and harmful effects of extended‐release formulations of methylphenidate in adults diagnosed with ADHD.